Clinical trials continue to face significant challenges in participant recruitment and retention. The Recruitment Innovation Center (RIC), part of the Trial Innovation Network (TIN), has been funded by the National Center for Advancing Translational Sciences of the National Institutes of Health to develop innovative strategies and technologies to enhance participant engagement in all stages of multicenter clinical trials. In collaboration with investigator teams and liaisons at Clinical and Translational Science Award institutions, the RIC is charged with the mission to design, field-test, and refine novel resources in the context of individual clinical trials. These innovations are disseminated via newsletters, publications, a virtual toolbox on the TIN website, and RIC-hosted collaboration webinars. The RIC has designed, implemented, and promised customized recruitment support for 173 studies across many diverse disease areas. This support has incorporated site feasibility assessments, community input sessions, recruitment materials recommendations, social media campaigns, and an array of study-specific suggestions. The RIC’s goal is to evaluate the efficacy of these resources and provide access to all investigating teams, so that more trials can be completed on time, within budget, with diverse participation, and with enough accrual to power statistical analyses and make substantive contributions to the advancement of healthcare.

Meteorites and Interplanetary Dust Particles (IDPs) are supposed to originate from asteroids and comets, sampling the most primitive bodies in the Solar System. They contain abundant carbonaceous material. Some of this, mostly insoluble organic matter (IOM), likely originated in the protosolar molecular cloud, based on spectral properties and H and N isotope characteristics. Together with cometary material returned with the Stardust mission, these samples provide a benchmark for models aiming to understand organic chemistry in the interstellar medium, as well as for mechanisms that secured the survival of these fragile molecules during Solar System formation. The carrier molecules of the isotope anomalies are largely unknown, although amorphous carbonaceous spheres, so-called nanoglobules, have been identified as carriers. We are using Secondary Ion Mass Spectrometry to identify isotopically anomalous material in meteoritic IOM and IDPs at a ~100-200 nm scale. Organics of most likely interstellar origin are then extracted with the Focused-Ion-Beam technique and prepared for synchrotron X-ray and Transmission Electron Microscopy. These experiments yield information on the character of the H- and N-bearing interstellar molecules: While the association of H and N isotope anomalies with nanoglobules could be confirmed, we have also identified amorphous, micron-sized monolithic grains. D-enrichments in meteoritic IOM appear not to be systematically associated with any specific functional groups, whereas 15N-rich material can be related to imine and nitrile functionality. The large 15N- enrichments observed here (δ15N > 1000 ‰) cannot be reconciled with models using interstellar ammonia ice reactions, and hence, provide new constraints for understanding the chemistry in cold interstellar clouds.